TODD STRATEGY GROUP

Lobbying for BIODESIX, INC. · Fully integrated molecular diagnostic company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Colorado · House · Senate · $30,000.00 income · posted Jul 19, 2025

Lobbying activity 2

Medicare/Medicaid

Medicare reimbursement for diagnostics. Medicare Contractor Reform.

Health Issues

Lab test regulatory and reimbursement reform.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.